1. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG (1987) Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 5:202?207
2. Berg SL, Balis FM, Zimm S, Murphy RF, Holcenberg J, Sato J, Reaman G, Steinherz P, Gillespie A, Doherty K, Poplack D (1992) Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol 10:143?148
3. Blaney S, Balis F, Murphy R, Arndt C, Gillespie A, Poplack D (1992) A phase I study of intrathecal mafosfamide in patients with refractory meningeal malignancies. Proc Am Soc Clin Oncol 11:274
4. Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG (1993) Plasma and CSF pharmacokinetic study of topotecan in nonhuman primates. Cancer Res 53:725?727
5. Blaney SM, Balis FM, Cole DE, Craig C, Reid J, Ames M, Krailo M, Reaman G, Hammond D, Poplack DG (1993) Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res 43: 1032?1036